SYRA Syra Health Corporation: מכפיל P/S עתידי

Syra Health Corp. (SYRA) operates entirely within the US, leaving its business fully insulated from external geopolitical risks and sanctions. The expected P/S ratio reflects market valuation trends, with the current parameter standing at 0.10. While the company generates revenue through IT contracts with the public sector and schools, it faces stringent HIPAA compliance requirements and significant regulatory barriers when deploying its digital products.

The forward P/S ratio trend reflects the scaling efficiency of Syra Health Corp. (SYRA) digital medical data logistics, where cloud-based supply chain optimization directly impacts revenue growth rates. This indicator benchmarks current market capitalization against projected sales, allowing investors to assess the fairness of the market value relative to expected margins and identify potential asset overvaluation risks.